Quality factor investing promises exposure to financially healthy companies with strong balance sheets and consistent profitability.
Ethereum is the leading platform for developers who want to build decentralized software applications, which are popular in areas like gaming and finance. Ether, which is Ethereum's native cryptocurrency, set a new record high during 2025, but it ended the year in the red.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The market is flashing a warning on several popular high-yield stocks that most income investors are ignoring. One key risk could completely reshape how these dividends are viewed. A seemingly safe yield may be closer to the chopping block than expected.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Verizon offers a high, near-7% yield and trades at a discounted ~8.5x P/E, below its historical average. I maintain a core long position in VZ, supplementing income with an options wheel strategy to enhance returns. Recent CEO transition raised dividend concerns, but management reiterated a strong commitment to sustaining shareholder returns and disciplined capital allocation.
Leading blue-chip dividend growth stocks appear to be untouchable, until you zoom out and see what's changed. A small shift in the macro could turn today's favorites into tomorrow's regrets. I detail why I'm walking away before most investors even notice the risk.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Eli Lilly (LLY) said Monday that it's lowering the price of its popular weight-loss drug Zepbound, about a month after striking a deal with the Trump administration to lower drug costs.
Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.